FDA批准 Stellest 镜片延缓6至12岁儿童的近视, FDA approves Stellest lenses to slow myopia in kids ages 6–12, reducing progression by 71%.

林业发展局已核准Essilor Stellest眼镜镜为6至12岁儿童使用近视镜,以减缓其发育速度。 The FDA has approved Essilor Stellest eyeglass lenses for children aged 6 to 12 with myopia to slow its progression. 镜片使用带有外围透镜的设计来制造光线脱焦,减少眼睛延长。 The lenses use a design with peripheral lenslets to create light defocus, reducing eye elongation. 临床试验显示,与标准透镜相比,近视进展减少了71%,两年来眼睛的长度减少了53%。 Clinical trials showed a 71% reduction in myopia progression and 53% less eye lengthening over two years compared to standard lenses. 没有发生严重的副作用,尽管有些曾经历暂时模糊或光晕。 No serious side effects occurred, though some experienced temporary blurriness or halos. 这是6岁儿童首个非接触透镜选择,为现有治疗提供更安全、更方便的替代方法。 This is the first non-contact lens option for children as young as 6, offering a safer, more accessible alternative to existing treatments.